Calcium-activated Neutral Protease (CANP), a Putative Processing Enzyme of the Neuropeptide, Kyotorphin, in the Brain
Overview
Authors
Affiliations
Kyotorphin (Tyr-Arg) accumulation in the dialysed synaptosol from the rat brain in the presence of an inhibitor of kyotorphin-degrading enzyme, was maximal at neutral pH. This accumulation was activated by calcium ions, but was inhibited by leupeptin and SH-blocking agents, a finding which suggests the involvement of calcium-activated neutral protease (CANP or calpain). In addition, the kyotorphin-precursor protein, being processed by purified mu- or m-CANP, was detected at about 160 kDa on Sephacryl S-300 chromatography of the synaptosol. The present findings seem to be the first evidence for the role of CANP as a processing enzyme of neuropeptide-precursor in nerve terminals.
Ueda H Front Med Technol. 2022; 3:662697.
PMID: 35047919 PMC: 8757751. DOI: 10.3389/fmedt.2021.662697.
Identification and optimization of a novel inhibitor of mitochondrial calpain 10.
Rasbach K, Arrington D, Odejinmi S, Giguere C, Beeson C, Schnellmann R J Med Chem. 2008; 52(1):181-8.
PMID: 19072163 PMC: 2801808. DOI: 10.1021/jm800735d.
Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration.
Vosler P, Brennan C, Chen J Mol Neurobiol. 2008; 38(1):78-100.
PMID: 18686046 PMC: 2726710. DOI: 10.1007/s12035-008-8036-x.
Comparison of antinociception induced by supraspinally administered L-arginine and kyotorphin.
Kawabata A, Manabe S, Takagi H Br J Pharmacol. 1994; 112(3):817-22.
PMID: 7921607 PMC: 1910193. DOI: 10.1111/j.1476-5381.1994.tb13152.x.
Kawabata A, Nishimura Y, Takagi H Br J Pharmacol. 1992; 107(4):1096-101.
PMID: 1467831 PMC: 1907944. DOI: 10.1111/j.1476-5381.1992.tb13413.x.